Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Brain Metastases|Lung Tumors|Breast Tumors
Interventions: DRUG: Lapatinib
Sponsor: Hellenic Cooperative Oncology Group